The Scientist

» patent and immunology

Most Recent

image: Single Patent for EU

Single Patent for EU

By | December 12, 2012

After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.

1 Comment

image: Maggot Medicine

Maggot Medicine

By | December 10, 2012

The healing powers of maggots may lie in their secreted proteins, which restrain the human immune response.

2 Comments

image: Opinion: Parachuting off the Patent Cliff

Opinion: Parachuting off the Patent Cliff

By | December 6, 2012

As the United States edges ever closer to the dreaded fiscal cliff, the pharmaceutical industry approaches a precipice of its own.

4 Comments

image: Normal Fat Tissue Metabolism

Normal Fat Tissue Metabolism

By | December 6, 2012

Adipose tissue plays an immune role in individuals of normal wieght.

0 Comments

image: Contributors

Contributors

By | December 1, 2012

Meet some of the people featured in the December 2012 issue of The Scientist.

0 Comments

image: Fat's Immune Sentinels

Fat's Immune Sentinels

By | December 1, 2012

Certain immune cells keep adipose tissue in check by helping to define normal and abnormal physiological states.

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Can Worms Alleviate Autism?

Can Worms Alleviate Autism?

By | November 27, 2012

Autism researchers are testing the ability of whipworm eggs to treat autism in a new clinical trial.

10 Comments

image: Chimp Patents Challenged

Chimp Patents Challenged

By | November 16, 2012

Three patents on transgenic apes in the European Union will be challenged by animal rights activists.

1 Comment

image: Inflammation for Regeneration

Inflammation for Regeneration

By | November 8, 2012

Inflammatory signals in injured zebrafish brains promote the growth of new neurons.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech